Resumen
Definición
Anamnesis y examen
Principales factores de diagnóstico
- unexpected onset
- apprehension and worry
- behavioral avoidance
- tachycardia
- positive PRIME-MD panic screen
- Panic Disorder Severity Scale (PDSS)
- GAD-7 cut score ≥10
Otros factores de diagnóstico
- palpitations; chest pain and discomfort
- nausea and abdominal pain
- dizziness
- perceptual abnormality
- respiratory symptoms
- reliance on safety cues
- paresthesias
- muscle shaking
- sweating
- fainting
- chills or hot flushes
Factores de riesgo
- history in first-degree relatives
- age 18 to 39 years
- female sex
- white and Native American ethnicity
- major life events
- comorbid disorders
- psychological factors
- asthma and respiratory variability
- cigarette smoking
- caffeine use
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- clinical assessment
Pruebas diagnósticas que deben considerarse
- ECG
- blood glucose
- thyroid function tests
- metabolic panel
- toxicology screen
Algoritmo de tratamiento
acute panic attack
panic disorder
panic attacks without panic disorder
Colaboradores
Autores
Craig N. Sawchuk, PhD

Professor
Department of Psychiatry and Psychology
Mayo Clinic
Rochester
MN
Divulgaciones
CNS declares that he has no competing interests.
Jason P. Veitengruber, MD

Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle
WA
Divulgaciones
JPV declares that he has no competing interests.
Revisores por pares
Tanveer A. Padder, MD
Chairman
Department of Psychiatry
Trinity School of Medicine
Warner Robins
GA
Divulgaciones
TAP declares that he has no competing interests.
Paul Blenkiron, BM BCh, MA
Consultant Psychiatrist
Leeds and York Partnership NHS Foundation Trust
Bootham Park Hospital
York
UK
Divulgaciones
PB declares that he has no competing interests.
Philip J. Cowen, MD, FRCPsych, FMedSci
Professor of Psychopharmacology
Warneford Hospital
Oxford
UK
Divulgaciones
PJC declares that he has no competing interests.
Toshiaki A. Furukawa, MD, PhD
Professor and Chair
Department of Psychiatry and Cognitive-Behavioral Medicine
Graduate School of Medical Sciences
Nagoya City University
Nagoya
Japan
Divulgaciones
TAF has received research funds and speaking fees from Astellas, Dai-Nippon, Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Meiji, Otsuka, Schering-Plough, and Yoshitomi. He was on a research advisory board for Meiji and Mochida, and is currently on research advisory boards for Sekisui chemicals and Takeda Science Foundation. He has received royalties from Igaku-Shion and Seiwa-Shoten Publishers. The Japanese Ministry of Education, Science, and Technology and the Japanese Ministry of Health, Labor, and Welfare have also funded his research.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision, (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Australian & New Zealand Journal of Psychiatry. 2018;52(12):1109-172.Texto completo
Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021 Mar 6;397(10277):914-27.Texto completo Resumen
Katzman MA, Bleau P, Blier P, et al; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada and McGill University. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14 Suppl 1:S1.Texto completo Resumen
Roy-Byrne P, Craske MG, Sullivan G, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA. 2010 May 19;303(19):1921-8. Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Agoraphobia
- Specific phobia
- Social anxiety disorder
Más DiferencialesGuías de práctica clínica
- Anxiety disorders in adults: screening
- Diagnostic and statistical manual of mental disorders: 5th edition, text revision (DSM-5-TR)
Más Guías de práctica clínicaFolletos para el paciente
Panic attacks: what are they?
Panic attacks: what are the treatment options
Más Folletos para el pacienteLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer